Mechanical embolectomy has become an important method for the treatment of acute ischemic stroke with large vessel occlusion. At present, the focus of mechanical embolectomy is to optimize treatment, improve recanalization rate, and reduce complications. The in vitro model has become a common and convenient method in the research of mechanical embolectomy, which is of great significance for the evaluation of new thrombectomy devices.
Taking the research needs of the Bioengineering Research Center of PLA General Hospital (301 Hospital) as the starting point, the surgical simulator manufacturer Preclinic continuously improves the in vitro experimental model according to the characteristics and application of in vitro experimental models.
Assisted Dr. Liu Ronghun's team in the bioengineering research center of the PLA General Hospital (301 Hospital) in the in vitro experimental evaluation of mechanical thrombectomy devices.
